- Home
- ICCC vs ABLV Comparison
ICCC vs ABLV Comparison
Compare ICCC & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- ABLV
- Stock Information
- Founded
- ICCC 1982
- ABLV 2015
- Country
- ICCC United States
- ABLV China
- Employees
- ICCC N/A
- ABLV N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- ABLV
- Sector
- ICCC Health Care
- ABLV
- Exchange
- ICCC Nasdaq
- ABLV Nasdaq
- Market Cap
- ICCC 47.4M
- ABLV 47.3M
- IPO Year
- ICCC 1987
- ABLV N/A
- Fundamental
- Price
- ICCC $5.20
- ABLV $1.25
- Analyst Decision
- ICCC
- ABLV
- Analyst Count
- ICCC 0
- ABLV 0
- Target Price
- ICCC N/A
- ABLV N/A
- AVG Volume (30 Days)
- ICCC 22.3K
- ABLV 17.9K
- Earning Date
- ICCC 05-14-2025
- ABLV 01-01-0001
- Dividend Yield
- ICCC N/A
- ABLV N/A
- EPS Growth
- ICCC N/A
- ABLV N/A
- EPS
- ICCC N/A
- ABLV N/A
- Revenue
- ICCC $26,493,169.00
- ABLV $128,932,647.00
- Revenue This Year
- ICCC N/A
- ABLV N/A
- Revenue Next Year
- ICCC N/A
- ABLV N/A
- P/E Ratio
- ICCC N/A
- ABLV N/A
- Revenue Growth
- ICCC 51.63
- ABLV N/A
- 52 Week Low
- ICCC $3.34
- ABLV $0.55
- 52 Week High
- ICCC $5.82
- ABLV $1.98
- Technical
- Relative Strength Index (RSI)
- ICCC 47.84
- ABLV 54.19
- Support Level
- ICCC $5.01
- ABLV $1.26
- Resistance Level
- ICCC $5.72
- ABLV $1.46
- Average True Range (ATR)
- ICCC 0.18
- ABLV 0.13
- MACD
- ICCC -0.04
- ABLV 0.00
- Stochastic Oscillator
- ICCC 37.50
- ABLV 47.47
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.